MedPath

Topical steroid in Managing Skin Involvement of Patients with Idiopathic Granulomatous Mastitis.

Phase 2
Conditions
Idiopathic Granulomatous Mastitis.
Inflammatory disorders of breast
Registration Number
IRCT20230822059222N1
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
40
Inclusion Criteria

A confirmed diagnosis of idiopathic granulomatous mastitis (IGM) based on histopathological examination
The patients should require non-surgical treatment for their condition
The severity of involvement should be grade II, III, or IV according to the modified classification of Yuan et al
Absent of breast carcinoma or other malignancies or systemic diseases such as vasculitis, collagen vascular disease, or sarcoidosis
Absent of a risk factor for steroid therapy, such as hypertension or diabetes mellitus

Exclusion Criteria

Lack of consent to participate in the study
The severity of the conflict is grade 1

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The disappearance of inflammatory signs. Timepoint: All Patients will be followed weekly in first month and then monthly for 5 months for detect symptoms. Method of measurement: The clinical response is categorized into completely healed, inadequately healed, stable, worsened, or relapsed that will be evaluated by surgeon.;Closure of fistula orifices. Timepoint: All Patients will be followed weekly in the first month and then monthly for 5 months to detect symptoms. Method of measurement: The clinical response is categorized into completely healed, inadequately healed, stable, worsened, or relapsed that will be evaluated by surgeon.;Disappearance of skin erosion. Timepoint: All Patients will be followed weekly in the first month and then monthly for 5 months to detect symptoms. Method of measurement: The clinical response is categorized into completely healed, inadequately healed, stable, worsened, or relapsed that will be evaluated by surgeon.
Secondary Outcome Measures
NameTimeMethod
Resolution of skin involvement. Timepoint: One year after starting the treatment. Method of measurement: Assessed by the surgeon.
© Copyright 2025. All Rights Reserved by MedPath